DNLI
Denali Therapeutics Inc.
Approval
Confirmed
AVLAYAH (tividenofusp alfa-eknm)
Hunter Syndrome (MPS II)
242d ago
Mar 25, 2026
SEC 8-K
verified 5mo ago
Countdown card →